These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 6474626)

  • 21. [Hormone-dependency of the human prostate].
    Robel P
    Bull Cancer; 1986; 73(1):19-22. PubMed ID: 2430651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytoplasmic androgen receptors in biopsy specimens of prostatic tumors].
    Kushlinskiĭ NE; Degtiar' VG; Bassalyk LS
    Lab Delo; 1983; (7):18-20. PubMed ID: 6194344
    [No Abstract]   [Full Text] [Related]  

  • 23. Androgen, estrogen, and progesterone receptors in peripheral and central zones of human prostate with adenocarcinoma.
    Bashirelahi N; Young JD; Shida K; Yamanaka H; Ito Y; Harada M
    Urology; 1983 May; 21(5):530-5. PubMed ID: 6857901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Androgen and estrogen receptors in intact, hyperplastic, peritumorous and malignant prostate tissues: a link to proliferation and apoptosis (immunochemical study)].
    Fedosenko KV; Koval'skiĭ GB
    Vopr Onkol; 2005; 51(2):216-8. PubMed ID: 16223004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the R-3327H rat prostatic adenocarcinoma to human benign prostatic hyperplasia and metastatic carcinoma of the prostate with regard to steroid hormone receptors.
    Dahlberg E; Snochowski M; Gustafsson JA
    Prostate; 1980; 1(1):61-70. PubMed ID: 6169071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of steroid receptors in prostate cancer: possibilities and limits].
    Lämmel A; Krieg M; Klosterhalfen H; Bressel M; Voigt KD
    Urologe A; 1986 Jan; 25(1):59-62. PubMed ID: 3962047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of estrogen and androgen receptor status in prostatic disease measured by high pressure liquid chromatography.
    Kirdani RY; Pontes EJ; Murphy GP; Sandberg AA
    J Steroid Biochem; 1984 Jan; 20(1):401-6. PubMed ID: 6200699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New data on relations between residual hormonal modulability and medical treatment of breast adenocarcinoma].
    Prodi G; Lollini PL; Nicoletti G
    Minerva Med; 1984 Feb; 75(6):219-21. PubMed ID: 6709205
    [No Abstract]   [Full Text] [Related]  

  • 29. [Technical problems in the demonstration of prostatic hormones].
    Ranft R
    Z Urol Nephrol; 1978 Oct; 71(10):689-92. PubMed ID: 735465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study on the concentrations of steroid receptors in adenomatous and cancerous prostatic tissue].
    Rio MC; Offner M
    J Steroid Biochem; 1982 Oct; 17(4):435-41. PubMed ID: 6182395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Steroid hormone receptors in malignant neoplasms of the human prostate gland].
    Bassalyk LS; Kushlinskiĭ NE
    Vestn Akad Med Nauk SSSR; 1984; (10):82-8. PubMed ID: 6506859
    [No Abstract]   [Full Text] [Related]  

  • 33. Methods for the determination of androgen receptor content in human prostatic tissue.
    Trachtenberg J; Hicks LL; Walsh PC
    Invest Urol; 1981 Mar; 18(5):349-54. PubMed ID: 7203958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The prognostic significance of determining androgen receptors in prostatic cancer].
    Kushlinskiĭ NE; Bassalyk LS; Svetozarskiĭ NL; Matveev BP; Gorilovskiĭ LM; Makarova GV; Bukharkin BV; Shakhov EV; Kliuchikhin OZ
    Urol Nefrol (Mosk); 1993; (1):7-10. PubMed ID: 7941132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prostatic cytoplasmic androgen receptor in prostatic disease. I. Serum androgen levels, cytoplasmic androgen levels and cytoplasmic R1881 receptor in prostatic disease].
    Kitano T
    Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1084-97. PubMed ID: 6334192
    [No Abstract]   [Full Text] [Related]  

  • 36. [Steroid hormone receptors in malignant tumors of the large intestine].
    Korotkova TV; Bassalyk LS; Knysh VI; Prorokov VV
    Vopr Onkol; 1984; 30(9):64-8. PubMed ID: 6495697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
    Habib FK; Chisholm GD
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
    [No Abstract]   [Full Text] [Related]  

  • 39. Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma.
    Takeda H; Akakura K; Masai M; Akimoto S; Yatani R; Shimazaki J
    Cancer; 1996 Mar; 77(5):934-40. PubMed ID: 8608487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
    Pavone-Macaluso M; Carruba G; Castagnetta L
    Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.